​

Cognition Therapeutics Ownership | Who Owns Cognition Therapeutics?

OverviewForecastFinancialsChartTranscripts

Cognition Therapeutics Ownership Summary

Cognition Therapeutics is owned by 24.74% institutional investors, 2.27% insiders, and 72.99% retail investors. Bios capital management, lp is the largest institutional shareholder, holding 9.42% of CGTX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.33% of its assets in Cognition Therapeutics shares.

CGTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCognition Therapeutics24.74%2.27%72.99%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bios capital management, lp6.00M9.42%$8.10M
Vanguard group3.32M4.26%$4.48M
Davenport2.87M3.68%$3.88M
Northwestern mutual wealth management2.06M2.64%$260.98M
Tang capital management1.20M1.88%$1.62M
Blackrock funding, inc. /de1.01M1.30%$1.37M
Chescapmanager997.03K1.28%$1.35M
Renaissance969.51K1.24%$1.31M
Geode capital management873.95K1.12%$1.18M
Jane street group614.26K0.79%$829.25K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bios capital management, lp6.00M9.11%$8.10M
Cm management200.00K0.23%$270.00K
Northwestern mutual wealth management2.06M0.17%$260.98M
Chescapmanager997.03K0.11%$1.35M
American financial group205.00K0.10%$276.75K
Tang capital management1.20M0.06%$1.62M
Hilton capital management548.95K0.06%$741.08K
Davenport2.87M0.02%$3.88M
Fca corp /tx52.54K0.02%$70.92K
Castle wealth management44.01K0.02%$59.41K

Top Buyers

HolderShares% AssetsChange
Northwestern mutual wealth management2.06M0.17%2.04M
Tang capital management1.20M0.06%1.20M
Vanguard group3.32M0.00%635.91K
Quadrature capital263.09K0.00%263.09K
Renaissance969.51K0.00%256.01K

Top Sellers

HolderShares% AssetsChange
Acadian asset management---701.94K
Awm investment company---650.00K
Timelo investment management---361.40K
Jane street group614.26K0.00%-311.89K
Aigh capital management---300.77K

New Positions

HolderShares% AssetsChangeValue
Tang capital management1.20M0.06%1.20M$1.62M
Quadrature capital263.09K0.00%263.09K$357.80K
Graham capital management226.56K0.00%226.56K$305.85K
Texas capital bank wealth management services123.30K0.01%123.30K$166.45K
Ci private wealth72.11K0.00%72.11K$97.35K

Sold Out

HolderChange
Jpmorgan chase-69.00
Opal wealth advisors-500.00
Nova wealth management-500.00
Ifp advisors-1.00K
Coldstream capital management-1.24K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202551-26.09%19,284,989-9.33%242.22%19-64.81%980.00%
Sep 30, 20256433.33%21,298,05889.46%3310.73%49172.22%4-42.86%
Jun 30, 202548-11,241,507-3.32%174.99%18-10.00%7-36.36%
Mar 31, 20251-97.78%6,000,000-45.80%91.29%--100.00%--100.00%
Dec 31, 202430-23.08%10,129,593138.12%2522.62%13-18.75%650.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv2.06M2.33%171.59K
Vanguard Institutional Extnd Mkt Idx Tr874.81K0.99%-
Fidelity Extended Market Index424.67K0.48%75.01K
Blackrock Extended Mkt Fund CF156.05K0.18%156.05K
Fidelity Total Market Index143.77K0.16%31.07K
BlackRock Extended Equity Market K64.70K0.16%-27.00
Extended Equity Market Fund K133.84K0.15%87.00
NT Ext Equity Mkt Idx Fd - L121.30K0.14%54.10K
Fidelity Series Total Market Index106.17K0.12%16.23K
iShares Micro-Cap ETF64.20K0.10%-

Recent Insider Transactions

DateNameRoleActivityValue
Jan 31, 2025Ricciardi Lisa CEO & PresidentBuy$30.00K
Mar 14, 2024Ricciardi Lisa CEO & PresidentBuy$9.97K
Nov 29, 2022RICHSTONE ELLEN B-Buy$26.55K
Nov 28, 2022Fletcher Aaron G.L.-Buy$4.96K
Nov 28, 2022Fletcher Aaron G.L.-Buy$5.23K

Insider Transactions Trends

DateBuySell
2026 Q1--
2025 Q4--
2025 Q3--
2025 Q2--
2025 Q11-

CGTX Ownership FAQ

Who Owns Cognition Therapeutics?

Cognition Therapeutics shareholders are primarily institutional investors at 24.74%, followed by 2.27% insiders and 72.99% retail investors. The average institutional ownership in Cognition Therapeutics's industry, Biotech Stocks , is 381.47%, which Cognition Therapeutics falls below.

Who owns the most shares of Cognition Therapeutics?

Cognition Therapeutics’s largest shareholders are Bios capital management, lp (6M shares, 9.42%), Vanguard group (3.32M shares, 4.26%), and Davenport (2.87M shares, 3.68%). Together, they hold 17.36% of Cognition Therapeutics’s total shares outstanding.

Does Blackrock own Cognition Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Cognition Therapeutics.

Who is Cognition Therapeutics’s biggest shareholder by percentage of total assets invested?

Bios capital management, lp is Cognition Therapeutics’s biggest shareholder by percentage of total assets invested, with 9.11% of its assets in 6M Cognition Therapeutics shares, valued at 8.1M$.

Who is the top mutual fund holder of Cognition Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Cognition Therapeutics shares, with 2.33% of its total shares outstanding invested in 2.06M Cognition Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools